|
Market Closed -
Swiss Exchange
19:31:48 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 129.58 CHF | -1.33% |
|
+3.96% | +18.23% |
| 12:58am | Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint | DJ |
| 12:52am | Ionis-Novartis heart drug misses main goal of late-stage trial | RE |
Chart: Technical Analysis
Swiss ExchangeCHF
| Markets | Quality | ||
|---|---|---|---|
NYSE
| NVS | Delayed | |
CBOE
| NVS | Real-time | |
|
Boerse Muenchen
| NOTA | Real-time | |
|
Tradegate
| NOTA | Real-time | |
|
Mexican S.E.
| NVS N | End-of-day quote | |
|
Deutsche Boerse AG
| NOTA | Delayed | |
|
Börse Stuttgart
| NOTA | Delayed | |
Swiss Exchange
| NOVN | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Xetra
| NOT | Delayed | |
|
Tradegate
| NOT | Real-time | |
|
OTC Markets
| NVSEF | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| Real-time | ||
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote | |
Swiss Exchange
| NOVNEE | Delayed | |
Buenos Aires S.E.
| NVS | End-of-day quote | |
|
Buenos Aires S.E.
| NVSD | End-of-day quote | |
Sao Paulo
| N1VS34 | Delayed | |
Toronto S.E.
| NVS | Delayed | |
|
Deutsche Boerse AG
| NOT0 | Delayed | |
Deutsche Boerse AG
| NOT1 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 133.73 | 138.09 | 145.59 |
| Spread/Res. | -3.10% | -6.16% | -11.00% |
| Spread/Supp. | +2.19% | +5.83% | +14.31% |
| Support | 126.8 | 122.44 | 113.36 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NOVN Stock
- Charts Novartis AG
Select your edition
All financial news and data tailored to specific country editions
